abhayrab rabies vaccine
Vaccineexperimental
Clinical trial activity
1 trials · 8 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Nov 6, 2020 (NCT04661579)
Timeline
2020s
- Jan 1, 2020
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Lyssavirus rabiesImmunity, active
Lyssavirus rabies immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04661579 | Phase 2 | Nov 6, 2020 | Bill and Melinda Gates Foundation, DF/Net Research, GlaxoSmithKline, Kenya Medical Research Institute, Kombewa Clinical Research Center, PATH, Triclinium Clinical Trial Project Management, United States Army |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (8)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Bill and Melinda Gates Foundation | Academic/Hospital | 1 | 0 | 1 | 2020 |
| DF/Net Research | For profit | 1 | 0 | 1 | 2020 |
| GlaxoSmithKline | For profit | 1 | 0 | 1 | 2020 |
| Kenya Medical Research Institute | Academic/Hospital | 1 | 0 | 1 | 2020 |
| Kombewa Clinical Research Center | Academic/Hospital | 1 | 0 | 1 | 2020 |
| PATH | Academic/Hospital | 1 | 1 | 1 | 2020 |
| Triclinium Clinical Trial Project Management | For profit | 1 | 0 | 1 | 2020 |
| United States Army | Government | 1 | 0 | 1 | 2020 |
8 organizations
Page 1 / 1